Chemical Structure:
C19H27NO
Mechanism of Action:
Acts as a kappa-opioid receptor agonist and a partial agonist or antagonist at mu-opioid receptors. This mixed activity can lead to less respiratory depression and a lower risk of dependence compared to full mu-opioid agonists.
Uses:
Moderate to Severe Pain: Often used in settings where the use of stronger opioids is to be avoided.
Side Effects:
Psychotomimetic Effects: Including hallucinations and confusion, particularly at higher doses.
Less Respiratory Depression: Compared to full mu-agonists, but still present.
Withdrawal Syndrome: If used after or with other full mu-opioid agonists.